Subarna Pharmaceuticals Private Limited
About Subarna Pharmaceuticals Private Limited
Data last updated:
Subarna Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 26 August 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1997PTC085268.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Riya Datta and Jolly Dutta.
Its last annual general meeting (AGM) was held on 15 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 12 Old Nimta Roadrani Park Belghoria, Kolkata, West Bengal, India – 700056.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.71 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹2.66 Lakh (net margin -71.7%) and EBITDA of -₹2.54 Lakh (EBITDA margin -68.4%).
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Subarna Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Old Nimta Roadrani Park Belghoria, Kolkata, West Bengal, India – 700056
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Subarna Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Subarna Pharmaceuticals Private Limited
FY 2020 filings availableSubarna Pharmaceuticals Private Limited reported revenue of ₹3.71 Lakh (down 52% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹3.71 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.54 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.66 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -68.4% | ||
| Net Profit Margin | -71.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Subarna Pharmaceuticals Private Limited, buy the company report.
Board of directors of Subarna Pharmaceuticals Private Limited
Subarna Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riya Datta | Director | 20 May 2013 | 13 Years 5 Months | Current |
| Jolly Dutta | Director | 27 Aug 1997 | 29 Years 2 Months | Current |
Auditor
Subarna Pharmaceuticals Private Limited is audited by BISWAS DASGUPTA DATTA & ROY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BISWAS DASGUPTA DATTA & ROY | FY 2017 | 302105E |
Shareholding
The shareholding of Subarna Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Subarna Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2000 | 90248003 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Subarna Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Subarna Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Subarna Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Subarna Pharmaceuticals Private Limited has 4 board changes on record since 1997: 3 appointments and 1 cessation. The latest: Binay Bhushan Datta ceased to be Director on 20 May 2013.
Frequently asked questions
Subarna Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in retail trading, within the trading industry. It was incorporated on 26 August 1997 (29+ years old) and is registered under CIN U24231WB1997PTC085268.
Subarna Pharmaceuticals has 2 current directors:
- Riya Datta - Director
- Jolly Dutta - Director
The latest financial statements of Subarna Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 15 September 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Subarna Pharmaceuticals is U24231WB1997PTC085268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Subarna Pharmaceuticals was incorporated on 26 August 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kolkata.
Binay Bhushan Datta ceased to be Director on 20 May 2013. Riya Datta was appointed as Director on 20 May 2013. Jolly Dutta was appointed as Director on 27 Aug 1997. Subarna Pharmaceuticals has 4 board changes on record in total.
The registered office of Subarna Pharmaceuticals is at 12 Old Nimta Roadrani Park Belghoria, Kolkata, West Bengal, India – 700056.
Subarna Pharmaceuticals operates in the trading industry, in the retail trading segment.
Subarna Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Subarna Pharmaceuticals is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
